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1. Introduction 
Biomaterial can be described as a combination of substances originating from natural, 
inorganic or organic materials that is biocompatible in exactly or partially contact with the 
body for healing time. They involve complete or part of a living organism or biomedical 
device which performs, augments or replacements any natural function [1].  
Biomaterial is a nonviable substance used in a medical device intended to interact with 
biological systems. Their usage within a physiologic medium needs the characteristic 
features such as efficient and reliable. These characteristic features have provided with a 
suitable combination of chemical, mechanical, physical and biological properties [2]. 
Nowadays, biomaterials are commonly used in various medical devices and systems; 
synthetic skin; drug delivery systems; tissue cultures; hybrid organs; synthetic blood 
vessels; artificial hearts; cardiac pacemakers; screws, plates, wires and pins for bone 
treatments; total artificial joint implants; skull reconstruction; dental and maxillofacial 
applications [3]. 
Metals and their alloys, polymers, ceramics and composites are commonly used for 
biomedical applications. These materials that have different atomic arrangement present the 
diversified structural, physical, chemical and mechanical properties and so different 
properties offer alternative applications in the body. The mechanical properties of metals 
and their alloys such as strength, elasticity coefficient and fatigue life makes them attractive 
materials for many load-bearing biomedical systems. Metallic materials tend to degradation 
in a corrosion process and even as the corrosion reactions of releasing some side products 
such as ions, chemical compounds and insoluble components that may cause adverse 
biological reactions.  
Ceramic materials are desirable biomaterials due to the biocompatible properties such as 
bioactive, bioinert and biodegradable, however they have significant disadvantages such as 
brittleness, low strength etc. [1-4]. 
Polymers are attractive materials for biomedical applications such as cardiovascular devices, 
replacement and proliferation of various soft tissues. They are also used in drug delivery 
systems, diagnostic supports and as a reconstructive material for tissue engineering. The 
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current applications of them include cardiac valves, artificial hearts, vascular grafts, breast 
prosthesis, contact and intraocular lenses, fixtures of extracorporeal oxygenators, dialysis 
and plasmapheresis systems, coating materials for medical products, surgical materials, 
tissue adhesives etc. [3]. The composition, structure and organization of constituent 
macromolecules specify the properties of polymers.  
Composite is a material comprised of two or more metal, polymer or ceramic structures 
which are separated by an interface. Composite materials have been widely used for a long 
time in innovative technological applications due to their superior mechanical properties. 
The bones, tendons, skin, ligaments, teeth, etc. are natural composite structures in the 
human body. The amount, distribution, morphology and properties of structure 
components determine the final behavior of resultant tissues or organs. Some synthetic 
composites can be used to produce prosthesis able to simulate the tissues, to compromise 
with their mechanical behavior and to restore the functions of the damaged tissues. 
Composites are usually classified based on their matrix components like metals, ceramics, 
polymers or reinforcement components like particulates, short or long fibers, microfillers, 
nanofillers. Many matrix and reinforcement components of composite materials have been 
tried by several researchers in tissue engineering to advance the mechanical features, 
biologic functions and to deliver special molecules. Biocompatible polymers have been 
mostly applied as matrix for composite materials associated with ceramic fillers in tissue 
engineering. Although ceramics are generally stiff and brittle materials, polymers are known 
to be flexible and exhibit low mechanical strength and stiffness. Composites aim to combine 
the properties of both materials for medical applications [1-9]. 
There are currently thousands of surgical materials, hard and soft tissue products, 
biomedical devices, pharmaceutical and diagnostic products and disposable materials at the 
medical market. The recent biomaterial applications were aimed to engineered tissues, 
intelligent materials, tissue cultures, drug delivery systems, artificial organs, biomimetic 
systems and materials in addition to traditional medical applications. Nowadays, modern 
clinical procedures such as preventing and curing main genetic diseases are become 
significant and new medical demands cause the change of the biomaterial products. 
Materials scientists and engineers need researchers who work effectively in professional 
teams such as molecular biologists, biochemists, geneticists and physicians and they also 
aim for the materials which are recognised by cells, biochemical structures, molecules and 
genetic issues [4]. 
2. Materials used in medicine 
2.1 Natural materials  
Biopolymers are natural materials such as carbohydrates, proteins, cellulose, starch, chitin, 
proteins, peptides, DNA and RNA produced by living organisms [10]. Generally, the 
synthesis procedure of them involves enzyme-catalysed polymerization reactions of 
activated monomers and chain growth which are characteristically formed within cells by 
complex metabolic processes [11]. Figure 1 shows classification, structures and functions of 
biopolymers. Table 1 also presents incidence and physiological functions of certain natural 
polymers.  
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(a) 
 
(b) 
Fig. 1. (a) Classification of biopolymers and (b) structure and functions of biopolymers [12].  
 
 Polymer Incidence Physiological Function 
Proteins Silk Synthesized by arthropods Protective cocoon 
Keratin Hair Thermal insulation 
Collagen Connective tissues (tendon, 
skin, etc.) 
Mechanical support 
Gelatine Partly amorphous collagen  
Fibrinogen Blood Blood clotting 
Elastin Neck ligament Mechanical support 
Actin Muscle Contraction, motility 
Myosin Muscle Contraction, motility 
Polysaccharides Cellulose (cotton) Plants Mechanical support 
Amylose Plants Energy reservoir 
Dextran Synthesized by bacteria Matrix for growth of 
organism 
Chitin Insects, crustaceans Provides shape and form 
Glycosaminoglycans Connective tissues Contributes to mechanical 
support 
Polynucleotides Deoxyribonucleic acid 
(DNA) 
Cell nucleus Direct protein biosynthesis 
Ribonucleic acid 
(RNA) 
Cell nucleus Direct protein biosynthesis 
Table 1. Incidence and physiological functions of certain natural polymers [12].  
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DNA is a natural polymer that has a great importance in all living creatures. DNA can be 
involved in the nucleus of every human cell and determines all of the physical 
characteristics through genes. Genes consist of a sequence of nucleotides that a specific 
protein is to be made. Hence the proteins carry out all of the functions of living organisms. 
Nucleotides are the monomers of DNA and each nucleotide consists of a 5-carbon sugar, a 
base and a phosphate. There are four bases named as Adenine(A), Thymine(T), Cytosine(C) 
and Guanine(G). The purines (Adenine and Guanine) have 5 carbons and the pyrimidines 
(Thymine and Cytosine) have 3 carbons. Purines are nitrogen containing bases consisting of 
two rings and pyrimidines are nitrogen containing bases with just one ring consisting of 
carbon and nitrogen. The nucleotides are linked covalently by carbon atoms and covalent 
bonding occurs between the sugar of one nucleotide and the phosphate in the backbone of 
the next. Each nucleotide is then paired up with their corresponding base (A to T and C to 
G). A weak hydrogen bond only holds the two base pairs together which makes DNA very 
easy to split and replicate. The linked nucleotides become a polynucleotide and named as 
the polymer of DNA (Figure 2a and 2b) [13]. 
              
        (a)                (b)  
Fig. 2. (a) DNA structure [14] and (b) double helix [15]. 
Polysaccharide is a macromolecule consisting of a large number of monosaccharide chains 
joined to each other by glycosidic linkages. Polysaccharides are made up chains of 
monosaccharide molecules which are linked together by glycosidic bonds and occurred by 
the condensation reaction. The linkage of monosaccharides into chains creates of greatly 
varying length ranging from chains of just two monosaccharide that make a disaccharide to 
the polysaccharides which consists of many thousands of the sugars. The polysaccharides 
play different and significant roles within the biological processes. [16]. The assembly of the 
polysaccharide is conducted by enzyme-driven reactions. It is the most spacious 
polysaccharide in nature and acts as a storage carbohydrate in many different parts of a 
plant. Starch, cellulose, glycogen and chitin are the basic polysaccharides used for medical 
applications. Starch is a combination of branched and linear polymers of D-glucose 
molecules generated by plants (Figure 3a). Starch contains only a single type of 
carbohydrate (glucose) [11].  
Cellulose is the most common carbohydrate in the world and is the main substance that 
forms most of a plant's cell walls. Its structure consists of long polymer chains of glucose 
units bonded by a beta acetal group. Cellulose structure has mostly a linear chain due to the 
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bond angles in the beta acetal group. The repeating monomer unit in starch structures is 
alpha glucose. Starch-amylose forms a spiral structure because of the bond angles in the 
alpha acetal groups (Figure 3b) [17]. 
      
                                     (a)                 (b) 
Fig. 3. Structure of (a) starch and (b) cellulose [17].   
Collagen is a main structural protein located in the body. It provides homogen strength to 
the tissues and organs of the body and comprises 90% of the organic matrix of bone together 
with the mineral, manages through the biomechanical properties and functional integrity of 
tissues.  Collagen that is in the shape of elongated fibrils is mostly included in fibrous tissues 
such as tendon, ligament and skin, and is also abundant in cornea, cartilage, bone, blood 
vessels and intervertebral disc. The collagen molecule has a distinctive feature that consists 
of three polypeptide chains. Proline, hydroxyproline and Gly-Prol-Hyp amino acids are the 
most common triplet found in collagen. The repeating sequence of these amino acids allows 
the chains to form a triple-helical structure. The arrangement of triple helices in fibrils is 
provide high tensile strength to this biopolymer [18]. 
Proteins are complex biopolymeric structures that are composed of up to 20 different amino 
acids. These amino acid units are sequenced by the template specific reamer of the 
polymerization process. Protein chains can contain a few hundreds or thousands of amino 
acid units (Figure 4). 
   
                     (a)            (b)  
Fig. 4. (a) Amino acid molecule (serin) and (b protein structure [13]. 
Chitin is a biopolymer of b(1/4)-linked N-acetyl-D-glucosamine residues (Figure 5a). Chitin 
is the second most abundant polysaccharide in nature and it is the basic structural 
component of the exoskeleton of invertebrates such as crustaceans, insects and spiders. It 
can also be found in the cell walls of most fungi and many algae. Chitosan is obtained from 
the alkaline deacetylation reaction of chitin and is a linear polysaccharide consisting of N-
glucosamine and N-acetyl glucosamine units linked by b(1/4) glycosidic bonds (Figure 5b). 
The deacetylation degree (DD: glucosamine/N-acetyl glucosamine ratio) usually can vary 
from 30 to 95% depending on the source.  
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                      (a)       (b) 
Fig. 5. Chemical structure of chitin (a) and chitosan (b).  
Alginate is the name given to linear polysaccharide family found in brown algae and is 
composed of guluronic and manuronic units. Alginate contains homopolymeric sequences 
such as polymer of (1-4) - ǃ -D-mannuronopyranosyl and (1-4)-L-guluronopyranosyl units 
in a copolymer [18]. Table 2 shows some applications of natural biomaterials. 
 
 
 
 
Application  Natural Biomaterial  
Artificial heart valves  Bovine pericardium, intact porcine aortic valves  
Hernia repair devices  Porcine small intestinal submucoa, porcine urinary bladder mucosa, porcine 
dermal grafts  
Sutures  Catgut (porcine or bovine intestinal wall), porcine dermal grafts  
Skin repair/ wound 
care  
Dermal allograft, porcine small intestinal submucoa, porcine dermal grafts  
Vascular prostheses  Bovine ureter, porcine small intestinal submucoa, ovine arteries  
Urethral repair  Porcine bladder  
Breast reconstruction  Dermal allograft  
Ligament repair  Dermal allograft, porcine small intestinal submucoa, fetal bovine skin  
Spinal fusion/bone 
healing  
Bone allograft  
 
Table 2. Some applications of natural biomaterials [19]. 
Natural products have many applications in the field of medicine, pharmaceuticals, 
diagnosis and treatment, food industry and agrochemicals etc. and they have a beneficial for 
the treatment of particular diseases on the human body. The recent research in natural 
biomaterials tends to many applications in various biomedical fields.  
2.2 Metals 
Metallic implant materials have significant economic and clinic importance on the medical 
applications for a long time. Many of metal and metal alloys such as stainless steel (316L), 
titanium and alloys (Cp-Ti, Ti6Al4V), cobalt-chromium alloys (Co-Cr), pure metals, precious 
metals, aluminium alloys, zirconium-niobium and tungsten heavy alloys were used for 
medical requirements (Table 3). The rapid growth and development of the many specialties 
of medicine has created whole new medical industry which was to supply more than a 
trillion dollars of medical products such as dental implants, craniofacial plates and screws; 
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parts of artificial hearts, pacemakers, clips, valves, balloon catheters, medical devices and 
equipments, bone fixation devices, dental materials, medical radiation shielding products, 
prosthetic and orthodontic devices, tools of machining metallic biomaterials. The main 
criteria in selection of metal-based materials for biomedical applications are their excellent 
biocompatibility, convenient mechanical properties, good corrosion resistance and low cost 
[4]. 
 
 
 
Medical Alloys Product Forms Medical Applications 
Stainless Steel Tube, pipe, wire, bar, strip, sheet, 
plate, screw, profile, clips, fixation 
devices, nails and pins, joints 
Dental and surgical instruments, medical 
devices 
Titanium Wire, spring Surgical implants, medical prostheses, dental 
implants, maxillofacial and craniofacial 
treatments, cardiovascular devices, surgical 
instruments 
Cobalt-Chromium Foil, strip, sheet, bracket, screws, 
surgical instruments 
Medical equipment 
NiTiNol Wire, Bar, rod, strip Surgical instruments, orthodontics, robotics 
Pure Metals Plate, profile Bone fracture fixation devices 
Precious Metals Forgings, castings Dental materials 
Aluminium Alloys Fasteners Medical radiation shielding products 
Zirconium-Niobium Machined parts Prosthetic and orthodontic devices 
Tungsten Heavy 
Alloys 
Prosthetic components Tools of machining metallic biomaterials 
 
 
Table 3. Medical metals and alloys for surgical implants and medical devices [5]. 
At the present time, the compatibility of improved diagnostic instruments and 
developments about the information on materials are supposed greater significance as well 
as on medical procedures [8]. Metals are used as biomaterials due to their excellent 
electrical, thermal and mechanical properties. Metals have some independent electrons 
which can transfer an electric charge and thermal energy fastly. These mobile free electrons 
act as the bonding force to hold the positive metal ions together. This strong attraction has 
proved by the closely packed atomic arrangement resulting in high specific gravity and high 
melting points of most metals. Since the metallic bond is not essentially directional, the 
position of the metal ions can be altered without destroying the crystal structure resulting in 
a plastically deformable solid [9]. 
Metallic biomaterials such as stainless steel, cobalt-based alloys, titanium and its alloys etc. 
form either face-centered cubic, hexagonal close-packed or body-centered cubic unit cells at 
body temperature with ideal crystal lattice structures as shown in Table 4. The most of metal 
crystals, in contrast to these ideal atom arrangements, contains lattice defects such as 
vacancies, dislocations, grain boundaries etc. (Figure 6). The presence of point, line and 
planary defects in metal internal structure has a strong effect on mechanical, physical and 
chemical properties.  
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Lattice Systems Bravais Lattices Examples 
Triclinic P  K2Cr2O7 
CuSO4.5H2O 
H3BO3 
 
Monoclinic  C  Monoclinic Sulphur 
Na2SO4.10H2O 
  
Orthorhombic P C I F Rhombic Sulphur 
KNO3 
BaSO4 
 
    
Tetragonal P I  White Tin 
SnO2 
TiO2 
CaSO4 
  
Rhombohedral P  CaCO3 
HgS 
 
Hexagonal P  Graphite (C) 
ZnO 
CdS 
 
Cubic P (pcc) I (bcc) F (fcc)  NaCl 
Zinc Blende (ZnS) 
Cu 
   
P: Primitive centered that includes the lattice points on the cell corners only; I: Body centered which 
finds one additional lattice point at the center of the cell; F: Face centered that consists one additional 
lattice point at center of each of the faces of the cell; A, B or C: Base centered which has one additional 
lattice point at the center of each of one pair of the cell faces. 
Table 4. The distribution of the 14 Bravais lattice types into 7 lattice systems [20]. 
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                    (a)           (b)            (c) 
Fig. 6. Defects of crystal structures: (a) point defects (substitutional or interstitial elements, 
vacancies) [21], (b) line defects (edge dislocation) [22] and (c) planar defects (grain 
boundaries) [23]. 
Interatomic bonding in solids occurs by strong primary ionic, covalent, and/or metallic 
bonds and weaker secondary interatomic bonding by van der Waals and hydrogen bonds. 
Metals are characterized by metallic interatomic bonding with valance shell electrons 
forming an electron cloud around the atoms/ions. As a result of the close positioning of 
neighboring atoms and the shared valence electrons, the non-directional interatomic 
bonding and electron movement within metal crystal lattices is easier than in ionic or 
covalently bonded materials. This fundamental distinctive feature of metals results in the 
relative ease of plastic deformation as well as the high electrical and thermal conductivities 
of metals. Most of the metals used for implant production have either close-packed atomic 
structures with face-centered cubic (fcc) or hexagonal close-packed (hcp) unit cells or nearly 
close-packed structures forming body-centered cubic (bcc) structures. The equilibrium 
distance between atoms defining the unit cells of these crystals and the strength of their 
interatomic bond is determined by intrinsic factors such as atom size and valency as well as 
extrinsic factors such as temperature and pressure. In addition to ease of deformation to 
desired shapes, the ability of deforming plastically at increasing loads results in another 
very important characteristic namely an ability to decrease sharp discontinuities through 
plastic deformation there by reducing local stress concentrations resulting in relatively high 
fracture toughness. These desirable features are dependent on proper selection of processing 
conditions for material and part formation [24]. 
Type of metal used in biomedical applications depends on functions of the implant. 316L 
type stainless steel (316L SS) is still the most used alloy in all implants part ranging from 
cardiovascular to otorhinology. However, when the implant requires high wear resistance 
such as artificial joints, Co-Cr-Mo alloys is better served. Table 5 summarizes surgical 
implant alloy compositions used for different biomedical applications [4]. 
The chemical properties of materials also are due to their atomic bonding types. Atomic 
bonding type changes the chemical, physical and mechanical properties of metallic 
materials. The surfaces of metallic medical products can be degraded in living systems and 
their changed surfaces can release some by-products to biologic medium. As a result of this 
releasing process, interactions between cell and tissues with metallic implant surfaces occur. 
For this reason, recent research gives great importance to surface properties of metallic 
products for the development of biocompatible materials.   
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Element 316L Stainless Steel 
(ASTM F138,139) 
Co-Cr-Mo 
(ASTM F799) 
Grade 4 Ti 
(ASTM F67) 
Ti-6Al-4V 
(ASTM F136) 
Al    -  - - 5.5-6.5 
C 0.03 max. 0.35 max. 0.010 max. 0.08 max. 
Co    - Balance - - 
Cr 17.0 26.0-30.0 - - 
Fe Balance 0.75 max. 0.30-0.50 0.25 max. 
H    - - 0.0125-0.015 0.0125 max. 
Mo 2.00 5.0-7.0 - - 
Mn 2.00 max. 1.0 max. - - 
N    - 0.25 max. 0.03-0.05 0.05 max. 
Ni 10.00 1.0 max. - - 
O  - - 0.18-0.40 0.13 max. 
P 0.03 max. - - - 
S 0.03 max. - - - 
Si 0.75 max. 1.0 max. - - 
Ti  - - Balance Balance 
V  - - - 3.5-4.5 
W  - - - - 
Table 5. Surgical implant alloy compositions (wt %) [6,7]. 
The mechanical properties of materials have a great importance during the design of the 
load-bearing dental and orthopaedic implants. With a few exceptions, the high tensile 
strength and fatigue limit of metallic materials make them the materials of chosen materials 
for implants that carry mechanical loads compared with ceramics and polymeric materials. 
It should be noted that, in contrast to the nanophase, composite nature of their constituent 
macromolecules. The properties of metallic biomaterials as hard tissue implants are 
compared below [25]: 
Stainless steel (SS)  
 cheaper than other metals, 
 has high strength, ductility and toughness, 
 easy machining, 
 can be corrosion problem, 
 can be less bone bonding than other metals, 
 may create nickel ion sensitivity. 
Co-Cr-Mo alloys  
 cast alloy forms have lower cost than wrought or forged forms,   
 cast alloys forms have higher elastic modulus than wrought or forged forms,  
 wrought or forged forms has the highest strength/wear resistance, 
 hardest to fabricate, 
 may produce cobalt or chromium ion sensitivity/toxicity. 
Titanium alloy (Ti-6Al-4V) versus Titanium (Ti) metal 
 titanium alloy is stronger than titanium metal, 
 both have relatively low elastic modulus, 
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 neither is as wear resistant as SS or Co-Cr-Mo alloys, 
 both have the best corrosion resistance,  
 both have excellent bone bonding.  
Types of Alloys Used in Medical Devices 
Several alloys are used in many medical devices; (1) silver-tin-mercury-copper alloys for 
dental amalgam fillers; (2) cobalt-chromium alloys for dental applications, cardiac valves, 
bone fracture and joint components; (3) titanium alloys for conductive leads, screws, joint 
components and nails and (4) stainless steels for bone fracture and joint components, stents 
and prosthetic materials (Table 6 and Figure 7). 
 
             (a)                                    (b)                              
 
         (c)                            (d) 
Fig. 7. (a) Nanostructured diamond coatings [26]; (b) ceramic and metal hip implant [27]; (c) 
metal ankle implants[28]; (d) coronary artery, metallic stent and stent procedure [29]. 
 
Application Metal 
Conductive leads Titanium and its alloys 
Dental amalgams Silver-tin-copper alloys, gold and platinum fillings 
Dental applications Cobalt-chromium alloys 
Fracture plates Stainless steel, cobalt-chromium alloys 
Guide wires Stainless steels 
Heart valves Cobalt-chromium alloys 
Joint components Cobalt-chromium alloys, titanium alloys 
Nails Cobalt-chromium alloys, titanium alloys 
Pacemaker cases Titanium alloys 
Screws Cobalt-chromium alloys, titanium alloys 
Vascular stents Stainless steel, nitinol 
Table 6. Medical applications of metals [30]. 
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Mechanical properties of metals used in medical applications are given in Table 7. Stainless 
steel has ultimate tensile strength values that range from 480 to 860 MPa and ultimate tensile 
strain values from 12 to 45%. In comparison, cobalt-based alloys have ultimate tensile 
strength values that can exceed 1,500 MPa and ultimate tensile strain values between 8% 
and 50%. Titanium alloys have ultimate tensile strength values up to about 900 MPa and 
ultimate tensile strain values between 10 and 24%. In comparison to polymers, metals have 
higher ultimate tensile strength and elastic modulus but lower strains at failure. However, 
in comparison to ceramics, metals have lower strengths and elastic modulus with higher 
strains to failure [30].  
 
Type and Condition Metal UTS (MPa) Yield at 2%a US (%) 
F55, F138 (annealed) Stainless  steel  480-515 170-205     40 
F55, F138 (cold worked) Stainless  steel  655-860 310-690     12-28 
F745 (annealed) Stainless  steel  480 min. 205 min.     30 min. 
F75 (cast) Cobalt-based alloy  655 450     8 
F90 (annealed)                           Cobalt-based alloy  896 379     30-45 min. 
F562 (solution annealed) Cobalt-based alloy  793-1,000 241-448     50 
F562(cold worked) Cobalt-based alloy  1,793 min. 1,586 min.       8 
F563 (annealed) Cobalt-based alloy  600 276     50 
F563 (cold worked and aged)   Cobalt-based alloy 1,000-1,586 827-1,310     12-18 
F67 Titanium alloy 240-550 170-485     15-24 min. 
F136 Titanium alloy 860-896 795-827     10 min. 
Note: UTS = ultimate tensile strength; US = ultimate strain; min. =minimum;  a Yield strength at 2% 
offset in MPs. 
Table 7. Mechanical properties of metals used in medical applications [30]. 
Nowadays, some metal implants have been replaced by ceramics and polymers due to their 
excellent biocompatibility and biofunctionality. However, the properties of high strength, 
toughness and durability are required for the metals. On the other side, clinical application 
of the promising research in using bioactive polymers and ceramics in regenerative 
medicine is still far away from practice. The future trend seems to combine the mechanically 
superior metals and the excellent biocompatibility and biofunctionality of ceramics and 
polymers to obtain the most desirable clinical performance of the implants. 
2.3 Polymers  
Polymers have been used widely in medicine and biotechnology [31], surgical devices [32], 
implants [33], drug delivery systems, carriers of immobilized enzymes and cells [34], 
biosensors, bioadhesives, ocular devices [35], dental materials [36], surface modification [37], 
biosensors [38], components of diagnostic assays [39], tissue adhesives [40] and materials for 
orthopaedic and tissue engineering applications [41]. This versatility requires the 
production of polymers prepared in different structures and compositions and appropriate 
physicochemical, interfacial and biomimetic properties to meet specific applications. The 
main advantages of the polymeric biomaterials compared to metal or ceramic materials are 
ease of manufacturability to produce various shapes such as membranes, films, fibres, gels, 
sheets, hydrogels, capsules, spheres, particles and 3D-structures (scaffolds) (Figure 8) and 
ease of secondary processability, reasonable cost and availability with desired mechanical 
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and physical properties. The required properties of polymeric biomaterials are 
biocompatibility, sterilizability, convenient mechanical and physical properties, and 
manufacturability as given in Table 8. Different polymeric materials and their biomedical 
applications are also presented in Table 9. The main types of polymers for biomedical 
applications derived from natural or synthetic organic sources.  
Table 10 presents the most important natural and synthetic origin polymers and their main 
biomedical applications. The principal disadvantages of these polymers are related to the 
difficulties in the development of reproducible production methods, because their complex 
structure often renders modification and difficult purification. In the case of synthetic 
polymers, these are available in a wide variety of compositions with modified properties.  
 
 
Fig. 8. Natural polymers used in biomedical applications such as tissue regeneration and 
drug delivery systems [42]. 
The main disadvantage of synthetic polymers is the general lack of biocompatibility in the 
majority of cases, often associated with inflammatory reactions [42]. For this reason, the 
recent researches have focused on the usage possibilities of natural origin polymers such as 
chitosan, carrageenan, alginate etc. 
 
Property Description 
Biocompatibility Noncarcinogenesis, nonpyrogenicity, nontoxicity, nonallergic response 
Sterilizability Autoclave, dry heating, ethylenoxide gas, radiation 
Physical property Strength, elasticity, durability 
Manufacturability Machining, molding, extruding, fiber forming 
Table 8. Required properties of polymeric biomaterials [9]. 
Polymer Application 
Poly(methyl methacrylate) Intraocular lens, bone cement, dentures 
Poly(ethylene terephthalate) Vascular graft 
Poly(dimethylsiloxane) Breast prostheses 
Poly(tetrafluoroethylene) Vascular graft, facial prostheses 
Polyethylene Hip joint replacement 
Polyurethane Facial prostheses, blood/device interfaces 
Table 9. Biomedical applications of different polymeric materials [43]. 
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Synthetic Polymer  Main Applications and Comments                                                 
Poly(lactic acid) 
poly(glycolic acid) and  
their copolymers  
Sutures, drug delivery systems and in tissue engineering, 
biodegradable, regulate degradation time during 
copolymerization 
Poly(hydroxyl butyrate) 
poly(caprolactone) and copolymers 
poly(alkylene succinate) etc.  
Biodegradable, used as a matrix for drug delivery systems, 
cell microencapsulation, to change the properties of materials 
by chemical modification, copolymerization and blending  
Polyamides (nylons)  Sutures, dressing, haemofiltration and blending  
Polyethylene(low density)  Sutures, catheters, membranes, surgical treatments 
Poly(vinyl alcohol)  Gels and blended membranes for drug delivery and cell 
immunoisolation  
Poly(ethylene oxide)  Highly biocompatible, different polymer derivatives and 
copolymers for biomedical applications  
Poly(hydroxyethyl methacrylate)  Hydrogels as soft contact lenses, for drug delivery, for skin 
coatings and immunoisolation membranes  
Poly(methyl methacrylate)  This and its copolymers in dental implants and bone 
replacements  
Poly(tetrafluroethylene) (Teflon)  Vascular grafts, clips and sutures, coatings  
Polydimethylsiloxanes  A silicone, implants in plastic surgery, orthopaedics, blood 
bags and pacemakers 
Poly(ortho esters)  Surface eroding polymers, application in sustained drug 
delivery, ophthalmology  
Polyanhydrides  Biodegradable, useful in tissue engineering and for the release 
of the bioactive molecules  
Table 10. Main properties and applications of synthetic polymeric biomaterials [42]. 
Polymers are large organic macromolecules consist of repeating units called ‘‘mers’’ which are 
covalently bonded chains of atoms. These macromolecules interact with one another by weak 
secondary bonds such as hydrogen and van der Waals bonds to form entanglement structure. 
Polymers exhibit weak thermal and electric properties because of the covalent interatomic 
bonding within the molecules. The mechanical and thermal behavior of polymers is influenced 
by several factors, including the composition of the backbone, chemical side groups, chain 
structures and different molecular weight. Plastic deformation that occurs when applied the 
mechanical forces cause the movement of macromolecule chains to one another. Changes in 
polymer composition or structure increase resistance to relative chain movement, so this 
resistance increases the strength and decreases the plasticity of the material (Figure 9). 
Substitutions into the backbone that increase its rigidity limit the chain movement. Large side 
groups also make disentanglement more difficult. Growing macromolecule chain also makes it 
less mobile and hinders its relative movement [6]. 
              
                  (a)           (b)                                (c)                                (d) 
Fig. 9. Structure of (a) ethylene [44], (b) polyethylene [44], (c) styrene [45] and (d) 
polystyrene [44]. 
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Polymers can be classified according to the polymerization techniques of the monomers. In 
bulk polymerization, only the monomer and possibly catalyst and initiator are fed into the 
reactor without solvent. At the end of the polymerization, process a nearly solid mass is 
removed as the polymer product. Bulk polymerization is employed widely in the 
manufacture of condensation polymers, where reactions are only mildly exothermic and 
viscosity is mostly low thus enhancing ready mixing, heat transfer and bubble elimination. 
Solution polymerization involves polymerization of a monomer in a solvent in which both 
the monomer (reactant) and polymer (product) are soluble. Suspension polymerization 
refers to polymerization in an aqueous medium with the monomer as the dispersed phase. 
Consequently, the polymer producing from such a system forms a solid dispersed phase. 
Emulsion polymerization is similar to suspension polymerization but the initiator is located 
in the aqueous phase (continuous phase) in contrast to the monomer (dispersed phase) in 
suspension polymerization. Besides, in emulsion polymerization the resulting polymer 
particles are considerably very smaller than those in suspension polymerization [46]. 
All polymers follow a degradation sequence in which the polymer is first converted to its 
monomers and then mineralization of monomers occurs. Most polymer molecules have too 
large size to pass through the cellular membranes, so firstly they have to depolymerize to 
smaller monomers before microbial cells absorbe them in biological system. The begining of 
polymer degradation during the chemical hydrolysis process can result different physical, 
chemical and biological forces. Physical forces such as heating/cooling, freezing/melting or 
wetting/drying can cause mechanical cracking of polymeric materials. These physical forces 
deteriorate the polymer surfaces and reveals the new surfaces for reaction with chemical and 
biochemical agents. This feature is a critical phenomenon in the degradation of solid polymers 
but  the chemical and biological forces of fluid polymers are more important [47,48].  
In recent years, advances of innovative technologies in tissue engineering, regenerative 
medicine, gene therapy and drug delivery systems have promoted through the need of new 
biodegradable biomaterials. Biologically and synthetically derived biodegradable 
biopolymers have attracted considerable attention. Polysaccharides and proteins are typical 
biologically derived biopolymers while aliphatic polyesters and polyphosphoesters are 
typical synthetic biopolymers. Specific biopolymers needed for in vivo applications are 
required because of the diversity and complexity of in vivo environments. Nowadays, 
synthetic biopolymers have become attractive alternative materials for biomedical 
applications for three reasons for most biologically derived biodegradable polymers: (1) 
may induce an immune response in the human body; (2) difficulty in chemical 
modifications; (3) change of the bulk properties after chemical modifications. To achieve the 
specific properties, properly designed synthetic biopolymers require further modifications 
without altering the bulk properties [49]. Table 11 lists the potential applications of these 
biodegradable polymers in tissue engineering. 
 
Polymer Tissue engineering 
Polyanhydrides Bone  
Polyurethane Vascular, Bone  
Polyelectroactive materials Nerve  
Polyphosphoester Bone  
Poly(propylene fumarate) Bone  
Polyesterurethane Genitourinary  
Table 11. The potential applications of biodegradable synthetic biopolymers [49]. 
www.intechopen.com
 A Roadmap of Biomedical Engineers and Milestones 
 
82
2.4 Ceramics 
Ceramics are used as parts of the musculoskeletal system, dental and orthopaedic implants, 
orbital and middle ear implants, cardiac valves, coatings to improve the biocompatibility of 
metallic implants. However, these biomaterials have been preferred less commonly than 
either metals or polymers. Some medical ceramics have presented are listed in Table 12 [6]. 
Ceramics used for repair and replacement of diseased and damaged parts of skeletal 
systems are named as biocompatible ceramics or bioceramics. Bioceramics have become a 
diverse variable class of biomaterials presently including three basic types: bioinert 
ceramics, bioactive ceramics which form direct chemical bonding with bone or even with 
soft tissues in biological medium, bioresorbable ceramics that actively participate in the 
metabolic activities in organism. Alumina (Al2O3), zirconia (ZrO2) and carbon are bioinert 
ceramic materials; bioglass and glass ceramics are bioactive and also calcium phosphate 
ceramics are categorized as bioresorbable. Bioceramics became attractive materials for 
medical applications, mainly in orthopaedics, maxillofacial surgery and dental implants. 
The biological evaluations of bioceramics are examined from the viewpoint of cytotoxicity, 
tissue irritability, bioceramic-tissue interface and cell adhesion to biomaterial surface in 
literature [50-52]. Figure 10 shows the main characteristics of ceramic materials [6].    
 
Ceramic Chemical Formula Comment 
Alumina 
Zirconia 
Pyrolytic carbon 
Al2O3 
ZrO2 
Bioinert 
Bioglass Na2OCaOP2O3-SiO Bioactive 
Hydroxyapatite 
Hydroxyapatite 
Tricalcium phosphate 
Ca10(PO4)6(OH)2   (sintered at high temperature) 
Ca10(PO4)6(OH)2   (sintered at low temperature) 
Ca3(PO4)2 
Biodegradable 
Bioinert:  material property that retains its structure in the body after implantation and does not induce 
any immunologic host reactions; Bioactive: material property that form bonds with living tissue; 
Biodegradable: material feature that degrade by hydrolytic breakdown in the body while they are 
being replaced by regenerating natural tissue; the chemical by-products of the degrading materials are 
absorbed and released via metabolic processes of the body. 
Table 12. Ceramics used in biomedical applications [6].  
 
Fig. 10. Main features of ceramic materials [53]. 
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The brittleness of bioceramics has severely restricted their field of application, leaving aside 
alumina (Al2O3) and zirconia (ZrO2), which are being used for hip joint prostheses. 
Bioceramics, phosphates in particular, could be used to manufacture ideal biomaterials due 
to their high biocompatibility and bone integration, as well as being the materials the most 
similar to the mineral component of the bones [54]. Alumina ceramic has desirable 
characteristics such as bioinert, high hardness, good abrasion resistance, excellent wear and 
friction behavior. These properties are associated with its surface energy and smoothness. 
This biomaterial has only one thermodynamically stable phase and a hexagonal structure 
with aluminium ions at the octahedral interstitial sites. The mechanical features of ceramic 
biomaterials are prescribed in Table 13. Good abrasion resistance, strength and inert 
behaviour of alumina in chemical medium have made it desirable ceramic material for hard 
tissue implants. The biocompatibility of alumina and zirconia ceramics have been tested and 
evaluated by many researchers. The results of these researches showed negative indication 
of implant rejection or prolapse of the implanted piece after many weeks of implantation 
and separately, fibroblast proliferation, vascular invasion and tissue growth in the pores of 
the implant were reported [52].  
 
Material Name Young’s Modulus 
(GPa) 
Compressive 
Strength 
(MPa) 
Bond Strength 
(GPa) 
Hardness Density 
(g/cm3) 
Klc 
(MPam1/2) 
Inert  Al2O3  380  4000  300-400  2000-3000 
(HV) 
>3.9  5.0-6.0  
ZrO2 (PS)  150-200  2000  200-500  1000-3000 
(HV) 
≈6.0  4.0-12.0  
Graphite(LTI) 20-25  138  NA  NA  1.5-1.9  NA  
Pyrolitic 
Carbon  
17-28  900  270-500  NA  1.7-2.2  NA  
Vitreous 
Carbon  
24-31  172  70-207  150-200 
(DPH)  
1.4-1.6  NA  
Bioactive HAP  73-117  600  120  350  3.1  <1  
Bioglass  ≈75  1000  50  NA  2.5  0.7  
AW Glass 
Ceramic  
118  1080  215  680  2.8  ≈2  
Bone  3-30  130-180  60-160  NA  NA  NA  
PS: Partially Stabilized; HA: Hydroxyapatite; NA: Not Available; AW: Apatite-Wallastonite; HV: 
Vickers Hardness; DPH: Diamond Pyramid Hardness 
Table 13. Mechanical features of ceramic biomaterials [54]. 
Ceramics are represented structurally ionic compounds such as sodium chloride. Atoms in 
sodium chloride are ionized by electron transfer making an ionic compound as a result of 
coulombic attractions. Negatively charged ions have increased atomic radii because they 
gain an electron and positively charged atoms have smaller radii because they lose an 
electron. The electronic attraction of the counter ions in the crystal structure gives rise to its 
stability. The simple and face-centered cubic structures of sodium and cesium chloride ions 
can be given as an example (Figure 11), respectively [30]. 
Structure-property relations of ceramic materials are composed of metallic and nonmetallic 
elements held together by ionic and/or covalent bonds. The interatomic bonds in ceramics 
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result in long-distance and three-dimensional crystalline structures but glass materials do 
not exhibit long-distance order. The electrons in ionic and covalent bonds are circumscribed 
between the constituent ions/atoms of the metallic bonds; therefore ceramics show the 
nonconductive property. The strong ionic and covalent bonds make ceramics hard and 
brittle, because the planes of atoms/ions cannot move one through another. For this reason, 
ceramics and glasses are sensitive to the presence of cracks or other defects during plastic 
deformation. The ionic and/or covalent nature of ceramics also influences their chemical 
behavior [6]. 
 
                                     (a)                                                           (b)          
Fig. 11. Unit cells and crystal structures of (a) sodium chloride (NaCl) [55] and (b) cesium 
chloride (CsCl) [56] crystals. 
Although ceramics and glasses resist to corrosive effects when exposed to the physiological 
environment, components of the ceramic structure make them sensitive to degradation 
media. The rate and mechanism of degradation depend on the structural properties of 
ceramic. Although alumina ceramic has mostly a bioinert character, its strength decreases in 
time during the immersion in simulated body fluids and after implantation.  Some cracks 
and crack propagation may accelerate dissolution of impurities so ceramic material 
degrades in the biological structure.   
Bioactive ceramics and glasses are also degraded in the body. [52]. Generally, degradation 
rate of materials depends on material composition, their functions and components of 
biological medium. The biodegradable (resorbable) ceramics  are used for applications such 
as drug delivery systems, repairing of damaged or diseased bone, bone loss, filling the 
implant system vacations, donor bone, excised tumors, repairing vertebra, herniated disc 
surgery, treatment of  maxillofacial and dental defects [53]. 
The brittleness and poor tensile strength properties of ceramic and glass implants are the 
main disadvantages. Although they can have exceptional strength during the compression 
loadings, ceramics and glasses fail at low stress under the mechanical loading such as 
tension or bending. Alumina and zirconia have the highest mechanical properties among 
biomedical ceramics. Low friction coefficient and wear rate are other advantageous 
properties of alumina. These properties of alumina and zirconia ceramics are used as a load-
bearing surface in joint replacements [6].  
Most of scientific works have been devoted to the interfacial reactions of biological systems 
with hydroxyapatite ceramic having chemical structure very similar to the mineral phase 
composition of bone. Hydroxyapatite is a popular surface coating material for stainless 
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steels, titanium and its alloys implants. In the recent time, researchers have investigated the 
probability of its use in composite forms that integrate polymers with ceramic or 
metal/ceramic combinations. There are significant researches performed on coating 
techniques, in-situ and biomimetic synthesis of apatites and the implications for ceramic 
properties and microstructure. The thermal and chemical stability of ceramics, high 
strength, wear resistance and durability properties contribute to making ceramics good 
candidate materials for surgical implants [57]. 
Calcium phosphate-based biomaterials and bioceramics are now used in a number of 
different applications throughout the body, covering all areas of the skeleton. Applications 
include dental implants, transdermic devices and use in periodontal treatment, treatment of 
bone defects, fracture treatment, total joint replacement, orthopaedics, cranio-maxillofacial 
reconstruction, otolaryngology and spinal surgery depending upon a bioresorbable or a 
bioactive material (different calcium orthophosphates). Figure 12 shows some commercially 
available ceramic medical products [58] and Table 14 also presents calcium phosphate based 
ceramics arranged by Ca:P ratio [54].     
    
                   (a)                            (b)                       (c)                       (d) 
Fig. 12. Ceramic products for medical applications (a) ceramic crown [59]; (b) 
hydroxyapatite block ceramic [60]; (c) ceramic implant systems [61]; (d) bio-eye 
hydroxyapatite orbital implants [62].  
The mechanical properties of calcium phosphates and bioactive glasses make them 
unsuitable as load-bearing implants. Clinically, hydroxyapatite has been used as filler for 
bone defects and as an implant in load-free anatomic sites such as nasal septal bone and 
middle ear. In addition to these applications, hydroxyapatite has been used as a coating 
material on metallic orthopaedic and dental implants to promote their fixation in bone. In 
this case, the fundamental metal surfaces to the surrounding bone strongly bonds to 
hydroxyapatite. Delamination of the ceramic layer from the metal surface can cause serious 
problems and results in the implant failure [6]. Intracorporeal implantable bioceramics 
should be nontoxic, noncarcinogenic, nonallergic, noninflammatory, biocompatible and 
biofunctional in the biological structure. 
Chemically, calcium orthophosphate bioceramics are based on HA (hydroxyapatite), ǃ-TCP 
(ǃ-tricalcium phosphate), ǂ-TCP (ǂ-tricalcium phosphate) and/or BCP (biphasic calcium 
phosphate). The BCP concept is determined by the optimal phase ratio between HA with ǂ-
TCP or ǃ-TCP phases.  Desirable bone tissue should have two clinical requirements: (1) 
pores size of the bone tissue grafts should be about 100 µm for biodegradation rate 
comparable to the formation of bone tissue between a few months with about two years and 
(2) their mechanical stability should be sufficient for clinical demand. HA is a more stable 
phase under the physiological conditions compared to ǂ-TCP and ǃ-TCP phases, as it has a 
lower solubility and a slower resorption rate. Calcined HA-based implants are applied for  
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Name Abbreviation Formula Ca/P 
Tetracalcium phosphate TetCP Ca4O(PO4)2   2.0 
Hydroxyapatite HAp Ca10(PO4)6(OH)2 1.67 
Amorphous calcium phosphate ACP Ca10-xH2x(PO4)6(OH)2  
Tricalcium phosphate (ǂ, ǃ, Ǆ) TCP Ca3(PO4)2  1.50 
Octacalcium phosphate OCP Ca8H2(PO4)6.5H2O 1.33 
Dicalcium phosphate dihydrate (brushite) DCPD CaHPO4.2H2O 1.0 
Dicalcium phosphate (monetite) DCP CaHPO4 1.0 
Calcium phosphate (ǂ, ǃ, Ǆ) CPP Ca2P2O7 1.0 
Calcium pyrophosphate dihydrate CPPD Ca2P2O7.2H2O 1.0 
Heptacalcium phosphate HCP Ca7(P5O16)2 0.7 
Tetracalcium phosphate diacid TDHP Ca4H2P6O20 0.67 
Calcium phosphate monohydrate MCPM Ca(H2PO4)2.H2O 0.5 
Calcium metaphosphate (ǂ, ǃ, Ǆ) CMP Ca(PO3)2 0.5 
Table 14. Calcium phosphates arranged by Ca:P ratio [54]. 
repair of the bone defects after implantation for many years, bioceramics made of ǃ-TCP, ǂ-
TCP, CDHA (calcium-deficient hydroxyapatite) or BCP are more preferable for medical 
purposes. According to both observed and measured bone formation parameters, calcium 
orthophosphates were arranged as low sintering temperature BCP (rough and smooth) ≈ 
medium sintering temperature BCP ≈ TCP > calcined low sintering temperature HA > non-
calcined low sintering temperature HA > high sintering temperature BCP (rough and 
smooth) > high sintering temperature HA (calcined and non-calcined). Figure 13 shows 
some randomly chosen examples of commercially available calcium orthophosphate 
bioceramics for use as bone grafts [63].  
 
Fig. 13. Various commercial calcium phosphate-based bioceramic products [63]. 
Bioresorption and bioactivity are the most important properties of calcium phosphate-based 
biomaterials. Even though the bone mineral crystals have a very large surface area, beside 
this, calcium phosphate bioceramics present lower surface area and strong crystal bonding. 
Because of this reason, disintegration of particles into crystals and the dissolution of crystals 
are involved in a resorption process. While cell activity forms the dissolution stage of 
crystals, insoluble calcium phosphates such as apatite or calcium pyrophosphates cannot be 
eliminated easily by cells and can reveal infected properties in other tissues. High sintering 
temperature (>900°C) decreases the resorption rate of HA ceramics, on the contrary 
(<900°C) increases [52]. Although HA sintered ceramics show osteoconductivity, their 
bioresorbability is low and HA remains in the body for a long time after implantation. 
Implanted materials should exhibit resorbable property through the bone regeneration 
followed by complete substitution for the natural bone tissue after stimulation of bone 
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formation. Therefore, recent research has been tend to TCP ceramics as scaffold materials for 
bone regeneration [64]. 
Calcium phosphate ceramics exhibit nontoxic behavior to tissues, bioresorption and 
osteoinductive property. Since ceramic/ceramic, ceramic/metal, ceramic/polymer 
composites include the different solid particle stiffeners, they need to the choice of more 
materials for implant applications. Consequently, the biological activity of bioceramics has 
to be known by various in vitro and in vivo studies and also data on mechanical feature 
would determined using by standard test methods to make the implant application and the 
choice of the bioceramic depending on the site of implantation easier [52]. Eventually, 
implantable bioceramics should be nontoxic, noninflammatory, nonallergic, 
noncarcinogenic, biocompatible and biofunctional for its working time in the host tissue. 
In consequence of bioceramics have generally structural properties and functions; they were 
used as joint or tissue replacements, coating materials to improve the biocompatibility of 
metal implants, temporary structures and frameworks to rebuild the damaged tissues in the 
body, drug delivery system for the treatment of damaged living organism. 
2.5 Composites 
Composites are engineering materials that contain two or more physical and/or chemical 
distinct, properly arranged or distributed constituent materials that have different physical 
properties with an interface separating them. Composite materials have a continous bulk 
phase called the matrix and one or more discontinuous dispersed phases called the 
reinforcement which usually has superior mechanical or thermal properties to the matrix. 
Separately, there is a third phase named as interphase between  the matrix and reinforced 
phases such as coupling agent coated on glass fibers to achieve adhesion of glass particles to 
the polymer matrix [65].    
Solid materials basically can be classified as polymers, metals, ceramics and carbon as a 
separate class. Both reinforcements and matrix materials are divided into four categories. 
Composites are usually classified as the type of material used for the matrix. The four main 
categories of composites are polymer matrix composites (PMCs), metal matrix composites 
(MMCs), ceramic matrix composites (CMCs) and carbon/carbon composites (CCCs). 
Recently, PMCs are the most commonly preferred class of composites. There are important 
medical applications of other types of composites which are indicative of their great 
potential in biomedical applications [66].  
The composite material usually includes reserved distinct phases that are separated on a 
scale larger than the atomic size. A synthetic composite material also consisted of 
continuous polymeric matrix phase and a ceramic reinforcement phase like natural 
biological materials such as bone, dentin, cartilage, skin.  The properties of this phase such 
as the elastic modulus are significantly altered when compared with a homogeneous 
structured material. Reinforced polymer matrices are fiberglass or natural materials such as 
bone. Bone, wood, dentin, cartilage and skin tend to be natural biological composite 
materials, beside these; natural foams include lung, cancellous bone, wood, sponge etc. 
Natural composites have hierarchical structures particulate, porous and fibrous structural 
features which are seen on different micro-scales [9]. 
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Composite materials consist of mixtures of polymers, metals and ceramics to form materials 
such as fiberglass, a mixture of glass fibers coated with a polymeric matrix. In recent years, 
scientific research tends to develop biomedical composite materials because of these 
materials present new alternative solutions for load-bearing tissue components. Composite 
materials are used limitedly in medicine for example high-modulus carbon fibers embedded 
in a polymeric matrix such as poly(lactic acid) and carbon-fiber-reinforced high molecular 
weight polyethylene are widely studied  for tendon, ligament, joint and facial implants [30].   
The structural properties are main feature of composite materials. Composites are different 
from homogeneous materials because of considerable control can be exerted over the larger 
scale structure, and hence over the desired properties. The properties of a composite 
material depend on the shape of the reinforcements, the volume fraction of them and 
interaction level of the interfaces of constituents. The categories of basic dispersed phase 
shape in a composite material are (1) particle; (2) fiber; and (3) platelet or lamina as shown in 
Figure 14. The dispersed phases may vary in size and shape within all category. For 
example, particulate dispersed phases may be spherical, ellipsoidal, polyhedral or irregular. 
If any phase consists of voids filled with air or liquid, the material is known as a cellular 
solid. If the cells have polygonal shapes, the material is a honeycomb form; if the cells have 
polyhedral shape, material has a foam form. These particulate shapes are necessary to 
construct the biomaterial to distinguish the above structural cells from biological cells which 
occur only in living organisms. Moreover, produced composite structure has to include 
random orientation and preferred orientation [67]. 
 
                                        (a)      (b)             (c)  
Fig. 14. Morphology of basic composite inclusions: (a) particle, (b) fiber, (c) platelet [67]. 
Metals have high strength, ductility and wear resistance properties. Most of many metals 
have low biocompatibility, corrosion, high stiffness and density, and metal ion releasing 
when compared to tissues. However the ceramic materials are exhibited good 
biocompatibility and corrosion resistance and high compression resistance, they also show 
brittleness, low fracture strength and production difficulties. But polymer composite 
materials provide alternative route to improve many undesirable properties of homogenous 
materials mentioned above.  
In general, tissues are grouped as hard and soft tissues, the bone and tooth are examples of 
hard tissues and skin, blood vessels, cartilage and ligaments are some of the soft tissue 
examples. The hard tissues have higher elastic modulus and stronger tensile strength than 
the soft tissues. Metals or ceramics chosen for hard tissue applications together with 
polymers prefferred for the soft tissue applications have to exhibit structural and mechanical 
compatibility with tissues. The elastic modulus of metal and ceramic materials is 10-20 times 
greater than values of the hard tissues. This difference is a major problem in orthopedic 
surgical materials between the bone and metallic or ceramic implants. Because of load 
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sharing between the bone and implant, it can create different stress distribution directly 
related to their stiffness [68]. 
Bone consisting of apatite mineral on collagen fibrils in different mass ratios form a 
composite material structure (Figure 15). Composite structure with a bioactive component 
will induce tissue growth to the implant and the formation of a strong bond between the 
tissue and implant after implantation process. [69]. 
 
Fig. 15. Bone structure [70]. 
Shape, size and distribution, volume ratio, bioactivity properties of the reinforcement or 
matrix phases; matrix properties such as molecular weight, grain size and distribution; ratio 
of the reinforcement in the matrix and reinforcement-matrix interfacial situation are largely 
affected to the properties of biomedical composites. Among these factors, properties of 
constituent materials have significant influence. However, architectural features of the 
composites such as the reinforcement percentage, distribution and orientation, etc. and 
reinforcement-matrix bonding condition also have strongly important roles. The mechanical 
and biological performance of bioactive composites relates to response various clinical 
requirements. The physical characteristics of the reinforcement such as shape, size and size 
distribution determines the mechanical properties of a composite. Spherical reinforcement 
shape which determined by mathematical modelling results achieved in the idealised 
situation provides good mechanical behavior for particulate composite material (Fig. 16a). 
Substantially, reinforcing bioactive particles may have to different shapes like irregular, 
platelet or needlelike. And the irregular shapes facilitate to the penetration of the molten 
polymer into gaps on the particle surface during high temperature composite processing. 
Thus, mechanical interlock between reinforced particle and polymer effectively form at the 
ambient or body temperature and even if a tensile stress is applied (Fig. 16b). The 
reinforcing bioactive glass or glass–ceramic particles which are made via the conventional 
glass–making method such as melting and quenching have sharp corners and take up the 
shape shown in Fig. 16c. These irregular shapes with sharp corners that cause stress 
concentration in the composites around are not preferred. The platelet shape is rarely 
encountered for particles in bioactive composites (Fig. 16d). Generally, particles prepared 
using by the precipitation procedure have to nanometer size and the needlelike shape are 
directly used for the composite materials (Fig. 16e) [69]. 
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Fig. 16. Shapes of bioceramic particles for biomedical composites: (a) spherical, (b) irregular 
flake, (c) irregular flake with sharp corners, (d) platelet, (e) needlelike [68]. 
Polymer composites are combination of two or more materials such as fillers, polymer 
matrix and binders especially structurally supplemental substances as if metal, ceramic, 
glass and polymer combine to produce structural or functional properties none of any 
specific component. Although the constituents protect identities of them and do not dissolve 
or merge completely into one another, they protect the rules of the integrity. Normally, the 
components of the composite body form an interface between two phases. The composites 
are divided in four main categories as composites with particles; composites reinforced with 
fibers; layered composites and sandwich structured composites [71].  
The most contribute factors to the engineering performance of the composite are: (1) 
materials that make up the individual components; (2) quantity, form and arrangement of 
the components and (3) interaction between the components. The shape, size, orientation, 
composition, distribution and manner of incorporation of the reinforcement system in a 
composite material strongly determine the desirable properties of material. Composite 
materials can also be simply classified as fiber-reinforced and particle-reinforced 
composites. Thus, there are four classes of composites: polymer-matrix composites (PMCs), 
ceramic-matrix composites (CMCs), or metal-matrix composites (MMCs). MMCs are 
prefferred rarely in biomedical applications and mostly used for high-temperature 
applications [65]. 
 
Fig. 17. Classification of composite materials [65]. 
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Figure 17 shows main types of biocomposites according to their reinforcement forms. Three 
kinds of reinforcements as short fibers, continuous fibers and particulates are typically used 
in preparation of the medical composites such as screws and total hip replacement stems 
made from short fiber reinforcements [68]. 
A typical external fixation system comprises of wires or pins that are pierced through the 
bone and keep under high tension by screws to the external frame. The wires oriented at 
different angles across the bone and their tensions are adjusted to provide necessary fixation 
rigidity. The external fixators are designed with high rigidity and strength to ensure the 
stability. Traditional designs are made of stainless steel which are heavy and cause patients 
to feel uncomfortable carrying the system for several months. CF/epoxy composite material 
is a good alternative for external fixator’s construction and gain currency owing to the fact 
that their lightweight, sufficient strength and stiffness [68]. Biocomposites used in the body 
are shown in Figure 18. 
 
Fig. 18. Biocomposites used in the body [68]. 
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The matrix determines the environmental durability of the composite by resisting chemical, 
hygroscopic and thermal stresses and protecting the reinforcement from these stresses. The 
matrix also greatly influences the processing characteristics of a composite material. 
Common matrices and reinforcements in biomedical composites are listed in Table 15. 
Thermoplastics are selected as matrix materials due to their nonreactive nature to produce 
biomedical composite materials. In spite of the thermosets have to inert feature; reactivity, 
flexibility and strength properties of some thermoplastics have redesigned to provide 
biodegradable behavior. Resorbable matrices are temporarily convenient to prepare a 
composite implant, but they are attractive to design a stiff reinforcing material that have a 
comparable degradation. Good compressive properties and bioactive possibilities of 
ceramics have also presented new matrix opportunities to produce the modified composite 
structures [65]. New matrix materials are developed constantly instead of ready for sale 
materials for medical applications. 
Composites can be made from constituents that have similar linear expansion constants. If 
they have distinct linear expansion constants, contact area (interface) between reinforcement 
and matrix materials can generates large voids through the contact surface,  therefore bone 
tissue engineers which produce the composite scaffolds have to behave more sense for the 
selection of the polymeric and bioceramic materials. The nature of the materials in a 
composite material usually requires the essential mechanical and/or chemical properties for 
the polymers and ceramics (and glasses). Materials that have the ability to degrade in vivo 
are ideal candidates for composite scaffolds which gradually degrade. During the 
degradation of calcium phosphate or bioactive glasses, the polymeric byproducts that form 
due to low pH values buffered to prevent the formation of inconvenient environment 
conditions for cells. 
 
 
 
Table 15. Constituents of biomedical composites [1]. 
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Bioceramic and glass materials are mechanically stronger than polymers and have a critical 
significant in providing mechanical stability to construct prior to synthesis of new bone 
matrix by cells. However, ceramics and glasses tend to destructive failure depending on to 
their intrinsic brittleness and defect sensitivity. It is required to obtain good chemical 
and/or physical bonding between polymer and inorganic phase to optimise the biological 
and mechanical performance of bioactive polymer/ceramic composites.  
Table 16 lists selected typical biodegradable and bioactive ceramic/glass-polymer 
composites that are designed for bone tissue engineering scaffolds and their mechanical 
properties. Literature reported an important composite scaffolds group that are tailored 
combinations of bioglass particles and biodegradable polymers such as PLGA, PDLLA, PHB 
having high application potential. These composites with porous structure have such 
mechanical properties that are close to cancellous bone and the high bioactivity is conferred 
by the bioglass particulate filler.  
 
Biocomposite Percentage 
of 
Ceramic 
(wt%) 
Porosity 
(%) 
Pore size 
(µm) 
Compressive 
(C) 
Tensile (T) 
Flexural (F) 
Strength 
(MPa) 
Modulus 
(MPa) Ceramic Polymer 
Non-crystalline CaP PLGA 28-75 75 >100  65 
ß-TCP Chitosan-
Gelatine 
10-70 - 322-355 0.32-0.88 (C) 3.94-10.88 
ß-TCP PLGA 30 - 400(macro) 
10(micro) 
- - 
HA PLLA 
PLGA 
PLGA 
50 
60-75 
85-96 
81-91 
30-40 
100x300 
800-1800 
110-150 
0.39 (C) 
0.07-0.22 (C) 
- 
10-14 
2-2.75 
337-1459 
nHA PA 60 52-70 50-
500(macro) 
10-50(micro) 
13.20-33.90 (C) 0.29-0.85 
HA PCL 25 60-70 450-740  76-84 
HA PLAGA 50-87 - - 80 (C) Up to 120 
Bio-glass® PLGA 75 43 89 0.42 (C) 51 
 PLLA 20-50 77-80 100(macro) 
10(micro) 
1.5-3.9 (T) 137-260 
 PLGA 0.1-1 - 50-300 - - 
 PDLLA 5-29 94 100(macro) 
10-50(micro) 
0.07-0.08(F) 0.65-1.2 
CaP glass PDLLA 20-50 93-96.5 80-450 - 0.05-0.2 
A/W  
Phosphate 
PLA- 
PDLLA 
40 
20-40 
93-97 
85.5-95.2 
 
98-154 
 
0.017-0.020 (C) 
 
0.075-0.12 
Glass PDLLA - - -   
Human cancellous 
bone 
- - - - 4-12 (C) 100-500 
 
Table 16. Typical biodegradable and bioactive ceramic-glass-polymer composites for bone 
tissue engineering applications and their mechanical properties [73].   
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Many studies suggest well-dispersed nanostructured composites that may offer surface 
and/or chemical properties closer to native bone and therefore they might represent ideal 
substrates to support bone regeneration. Recently, nanosized bioactive ceramic and glass 
particles have become available which can be considered as ideal fillers for tissue 
engineering scaffolds. However, problems associated with poor interfacial bonding and 
particle agglomeration may be more pronounced when using nanosized particles. Coupling 
agents have been employed as well as titanates and zirconates to improve the bonding 
between inorganic particles and matrix [72]. 
Fibre reinforced composite materials are widely prefferred for hard-tissue applications such 
as skull reconstruction, bone fracture repair, total knee, ankle, dental, hip and other joint 
replacement applications [73]. Considerably, the mechanical properties of composite 
materials depend on the direction of loading and the volume fraction of fibers. Low volume 
fraction of fibers decreases the modulus of the composite and requires a critical volume 
fraction approach for the modulus of the composite fibers. The modulus of cartilage and 
collagen fiber in a matrix of glycosaminoglycan and the tensile strength of skin, thick 
collagen fiber and glycosaminoglycan can be given as examples of the mechanical properties 
of composites. Biomedical composites which show continuous progression are very 
attractive and promising engineering materials made from two or more constituents with 
different physical properties [74]. 
3. Components of living systems 
3.1 Structure and properties of cells and tissues 
Cells the smallest living unit of an organism and each cell maintains all necessary functions 
to survive and represent the organism’s genetic code in its linear chemical cord (deoxyribo 
nucleic acid -DNA). They also evolve by the time or environmental changes; keep those 
records of experiences and can transfer this information to surrounding neighbor cells or 
next generations. Cells act like a power plant that requires raw material to produce energy 
and function. Each cell has a programmed life-span and predetermined function organized 
by the genetic code. According to their encoded function cells differentiate and develop 
specific features both functionally and physically during the intrauterine life. 
All cells have certain components that enable them to maintain their vital life processes. 
Those components are responsible to carry out different functions of the cell [75,76].  Cell 
membrane is a bilayered phospholipid barrier that separates the interior colloidal 
suspension (cytoplasm) of all cells from the outside environment (Figure 19).  
 
Fig. 19. Lipid bilayer model of a cell membrane. Circular polar portions making internal and 
external borders are made of phosphoglycerides (hydrophobic lipid), while inner portion of 
the molecule is hydrocarbon (hydrophilic). 
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Exterior and interior surfaces of cell membrane are lined with lipid pole of phospholipid 
molecules, while hydrophilic phospho-poles locate in the middle zone of the membrane. 
Randomly spread protein molecules, acting like a gated between inner and outer spaces, 
located in that bilayered cell membrane, of which main function is transportation of some 
molecules (Figure 20). Carbohydrates take place at cell membrane in combination with 
proteins as glycoproteins and fat acids as glycolipids.  Both these carbohydrate containing 
molecules (glycocalyx) cover outer surface of cell and repulse negative charged molecules or 
cells.  
 
Fig. 20. Fluid-mosaic model of cell membrane. Phospholipid is the major component of the 
bilayer lipid structure. Protein molecules float within this bilayered structure. 
Filtering substances is a selective operation, which essential to maintain homeostatic 
environment inside the cell to keep vitality of the organism. Even though cell membrane is 
selective barrier fulfilling passive diffusion, it may not be able to keep the equilibrium 
between inner structure and outer environment (homeostasis). Certain ions or molecules 
may require to be moved in or out with enforcement of transporter molecules of cell. This 
active transportation procedure requires energy. 
Common components of functioning cells (organelles) are: 
 Nucleus: contains DNA and controls functions of cell, 
 Mitochondria: power generator of the cell and control water and mineral level of 
cytoplasm and responsible from metabolic functions, 
 Endoplasmic reticulum: Tubular network among nucleus and cell membrane, 
responsible from inner transportation and storage, 
 Golgi apparatus: Responsible from sorting and storage of protein products of the cell, 
 Lysosome: Digestion of proteins, lipids, and carbohydrates and transportation of waste 
materials to cell membrane, 
 Ribosomes: Function for protein synthesis.  
Organized gathering of similar cells providing a specific function as a part of organ or 
organism is called as tissue. Tissues have their own purposeful union to fulfil their main 
function. Several types of tissues assemble in structural unit to serve a common function and 
named as “organ”. In an organ usually there is a main tissue (parenchyma), which executes 
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the organ function. In order to maintain vital functions and integrity of parenchyma 
supportive tissue (stroma), vessel tissues and nerve tissues take part in an organ. “Organ 
system” term is used for collection of several organs working together to fulfil a function, 
for example digestive system [75,76]. 
3.2 Biomolecules and their behaviors 
Biomolecules are main components of living cells (also their raw digestion materials) and at 
the same time their end-products, can also have an important role in signal transmission 
inside the cell or among other cells. Those molecules are also responsible from many 
functions like regeneration, survival and death. Several classifications can be made for their 
structures and functions. They can be a single molecule or in polymer form as well.  
Roughly saccharides, lipids, amino acids are the basic counterparts of more complicated 
molecules like proteins, vitamins, hormones and enzymes. Fundamental functions like 
digestion and replication are performed in a programmed cascade via several molecules 
under the control of DNA molecule. DNA is a double stranded polymer of the same four 
types of monomers (nucleotides). A base molecule, which may be either adenine (A), 
guanine (G), cytosine (C) or thymine (T) binds to a sugar (deoxyribose) with a phosphate 
group attached to it, forms this nucleotide monomer, which also can be called as building 
block of a single DNA strand (Figure 21). Those monomers bind one another with sugar 
phosphate linkages.  
 
Fig. 21. Structure of DNA. 
A DNA strand attached its pair with weak hydrogen links (adenine to thymine, cytosine to 
guanine), which permits two DNA strands to be separated without breakage. Each those 
DNA strands are templates for the synthesis of a new DNA strands during cell division to 
produce new cells. 
DNA has more responsibilities than replication but also synthesis of protein and ribonucleic 
acid (RNA) to maintain its vital functions.  This process begins with transcription of some 
DNA segments and forms RNA polymers that are used as templates for several molecules 
like proteins or enzymes. In other words DNA contains templates of all molecules that it is 
responsible to produce. 
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Amino acids, in other terms backbones of protein polymers, present diversity from DNA or 
RNA and 20 types of amino acids are used as base monomer for protein (polypeptide) 
synthesis. This variety brings different structural and behavioral nature diversity for 
proteins, like maintaining structures via enzymatic activity, movement of cell, sensing any 
inner or outer signal. According to their genetically encoded nature each protein molecule is 
responsible from a specific function. Enzymatic action of proteins is mainly dependent their 
amino acid arrays and location which determines the nature of the enzyme (destruction, 
digestion, catalization or synthesis function) [76].  
3.3 Host response to materials 
3.3.1 Inflammation, wound healing, and the foreign body response 
Simply, tissue response to any kind of injury can be named as inflammation. Injury is the 
starting point of protective biomechanism, which triggers wound healing to restore the 
damaged part of organism. 
 Physical trauma, like traffic accidents,  
 Thermal injuries, like sun or fire burns and electrical burns,  
 Chemical injuries, like contact with acidic or alkali solutions or poisoning or chemically 
irritant material, and 
 Biologic invasion (infections) by microorganisms, like bacteria, virus or fungi can cause 
tissue injury. Owing that information; it is important to emphasize a common mistake 
that infection is not a synonym for inflammation, but one cause of inflammation. 
Following sudden onset of signal injured vessel system and some local blood cells produce 
initial response by releasing some biochemical molecules that give first protective reaction 
to the injury cause and some other produce a chemical signal to attract the white blood cells, 
which are responsible from body defence, to let them migrate to the injury site. 
Inflammation stage can also be considered as the first step of wound healing. If the integrity 
of vessel is interrupted by the injury platelets (thrombocytes) begin to adhere the wound 
edges and one another to produce clot plug. By the aggregation of platelets they also release 
some molecules trigger clotting mechanism to produce clot plug. Those vessels or platelet 
originated molecules increase vessel permeability leading transfusion water from vessel 
lumen into the injured tissue site, which causes swelling of the tissue (edema). To ease 
arrival of chemically induced migrating (chemotaxis) of white blood cells; those released 
biomolecules also loosen muscles surrounding vessels, which are responsible to control 
blood flow via altering diameter of vessels, and increase vessel diameters. Therefore, the site 
looks reddish due to dilated blood vessels. Fibroblasts, likewise white blood cells, have the 
ability of chemotaxis to infiltrate the injury area to start reparatory phase. Some of these 
released molecules are pain mediators to warn our nerve system to attract our attention to 
take care our wound. 
As the white blood cells arrive the site they begin to struggle with the target caused injury 
and beside begin to resorb the blood clot to restore vessel lumen, so that blood stream to be 
maintained. Some white blood cells release molecules to neutralize the threat chemically 
and some others try to resorb the foreign material in small pieces to relive it (see section 
3.4.2). Simultaneously fibroblasts begin to produce connective tissue, which will be replaced 
with clot until local tissue regeneration takes place. Epithelial cells (responsible to cover our 
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body and make a barrier in between outer environment and inner medium) begin to 
replicate and grow to create a new cover over the wound area [75,76].  
As the source of injury (foreign body) is eliminated and the tissue is regenerated and take 
the action again wound healing process is completed. However, if the foreign body, 
sometimes implant or biomaterial, remains inside the body. On that point; it is critically 
important that whether the material giving threatening chemical signals, or not. If the 
remaining material is biocompatible, following the initial acute response, it can get along 
well with the surrounding tissues and may survive inside the organism.  
On contrary if the chemical signals of implanted material are recognized as a threat and 
cannot be terminated, defence system activates rejection mechanism (foreign body reaction) 
to withdraw the foreign body. Inflammatory reaction continues beside work out of 
fibroblasts, which knit a connective tissue net around the foreign body to isolate and put this 
material in quarantine for any possible further threats. As release of inflammatory 
biomolecules continues swelling, pain and reddish appearance sustains until the 
withdrawal. This process is called as foreign body reaction and presents a chronic 
development. 
3.3.2 Immunology and the complement system 
Our environment is rich of bacteria, viruses, fungi, and parasites and we are in contact with 
these external threats continuously via our skin, eyes, digestive, respiratory and 
genitourinary systems. Each attack of those organisms could have been lethal for us, if our 
body had not got any protection mechanisms. Defence system of human organism against 
hazardous factors is immune system. This system is not only responsible to fight with those 
invader organisms, but also has the obligation to neutralize chemical agents sensed as a 
threat for the organism. This system is sensitive to the dangers developing internally, like 
tumoral pathologies and sometimes can struggle with our natural structure itself.  
Immune system is consist of two major components; cellular and biochemical reactions. 
Cellular reaction is carried out by the white blood cells produced partly bone marrow and 
lymph vessels. Polymorphonuclear neutrophils, polymorphonuclear eosinophils, 
polymorphonuclear basophils, monocytes, lymphocytes, and plasma cells act like soldiers in 
this battle. They destroy invading microorganisms by engulfing (phagocytosis), especially 
neutrophils and macrophages. 
Second defence mechanism to eliminate or inactivate biologic or chemical agents is 
biochemical defence. This neutralization process can be innate or adaptive (acquired). Some 
natural secretions of our organ systems, like acid release of stomach, some digestive enzyme 
secretion of several organs of digestive system can kill the bacteria entered to our digestive 
canal. A mucolytic polysaccharide, lysozyme, which is a component of sweat and tear, can 
dissolute the microorganisms or some basic polypeptides can react with and inactivate 
certain types of gram-positive bacteria. 
The complement system of about 20 proteins including serum proteins, serosal proteins, and 
cell membrane receptors, generally synthesized by the liver, is found in the blood as inactive 
precursors. When stimulated by one of several triggers system that can be activated to 
destroy bacteria. Triggered system can initiate a chain reaction forming antibodies and 
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sensitized lymphocytes to destroy the responsible target. They account for about 5% of the 
globulin protein fraction of blood serum.  
Immunoglobulins (antibodies) are synthesized by B-lymphocytes. These glycoprotein 
molecules can tag a microorganism, infected cell or chemical-threat agent (antigen) and 
deactivate them. Antibodies can be non-specific as found in normal blood stream or can be 
synthesized to destroy one target selectively. 
3.3.3 Systemic toxicity and hypersensivity 
Of the most important features of biomedical materials non-toxicity, in other terms material 
must not harm the living organism. Damage of substance to the organism may vary from 
mild local response to (sometimes) lethal generalized reactions. Acute toxicity can be 
explained as damaging affects to an organism with a single or short-term exposure. Any 
natural or artificial substance (animal or plant secretions or extracts, inorganic materials, 
drugs) may damage the living tissues gradually related with their potency, doses and 
administration way and metabolism. Even materials like inevitable components of cells, like 
water, or even oxygen, may be harmful for our organism in higher doses. Pure substances 
may have toxicity risk solely, correspondingly compound materials, that contain more than 
one component have a different risk rate for each ingredient. Some components may induce 
toxicity rate of each other or may act a synergic action to harm organism. The damage to 
living structures, correspondingly with the amount of substance, may occur in many 
cascades of internal or external cell functions or structures. 
Chronic toxicity is the ability of a substance to cause harmful effects over an extended 
period (sometimes for the entire life), usually on repeated or continuous exposure. 
Therefore, corrosion, degradation or decomposition of material placed inside the body is, 
unless designed to act in this direction, is not desired due to the risk of local or systemic 
toxicity risk. As the toxicity occurs; depending its damage level, patients’ complain may 
vary from local irritation to life-threatening severe condition clinically until the reason of 
toxicity is removed or neutralized. 
Deactivation process of any molecule sensed as a threat (antigen) by immune system is 
allergic reaction. Several defence mechanisms are initiated locally and neutralize the 
antigen. However; sometimes, no matter what the amount of antigen entered to the body it 
may trigger chain-reaction over the normal limits and carries the reaction via chemical 
signalling all around whole body and described as hypersensitivity reaction. The patient 
could have been pre-sensitized by multiple exposures to the antigen until that time. No or 
mild previous reactions due to the antigen contact can be reported by the patient and 
sudden onset of hypersensitivity may occur at a severe level. On the other hand; the 
organism may have a genetic potential to generate this over-reaction, which means 
hypersensitivity reaction may occur during the first introduction with the antigen material 
and can be lethal.  
3.3.4 Tumorogenesis and biomaterials  
Reproduction of healthy cells is division of cells (mitosis). DNA controls the frequency of 
mitosis, likewise all functions of cell. During the life span of a healthy cell DNA carries a 
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code to end cell life and programmed cell death (apoptosis) occurs. However, some external 
factors, like chemical agents, radiation, some bacteria or virus infections, may cause a 
change on the DNA structure (mutation) or pre-determined genetic code is deteriorated 
during normal life span [75,76]. These mutagenic alterations lead DNA to lose its inhibitory 
control on mitosis or moreover induce continuous cell division. Additionally or on the other 
hand; the genetic mutation may clear apoptosis order of the nature and continually dividing 
cells can survive forever. Both mechanisms cause unstoppable cell number increase inside 
the body, called as tumourogenesis (tumour formation).Some substances induce cell 
division via DNA mutation and cause tumour formation, while some, like ethyl alcohol and 
oestrogen, may promote mitosis and lead cancer. Similarly; continual physical, chemical, 
electrical or electromagnetic stimuli, behave as chronic irritation and trigger the healing 
mechanism, which means inducing cell division to repair the injured area. Unless the factor 
reasoning promoted cell division is relieved cancer out-breaks would be faced. Those are the 
mainly accepted carcinogenic theories, which give the clues to be considered, while 
biomaterial production is concerned.  
3.3.5 Implant-associated infection 
A material or object placed in to an organism to restore a function, mass loss or to measure, 
diagnose or treat any condition is called as “implant”. Implants’ success is directly related to 
their survival. Life expectancy of the implants can be interfered with several endogenous or 
exogenous factors [77]. Least but not the last issue considering implant failure is the infection. 
Implant, as a foreign material has a risk to undergo rejection. Therefore; implants are produced 
of biocompatible materials and sterilized before placement into the body. As antimicrobial 
body protection is carried out by our skin and mucosal barrier, inner environment of the body 
is sterile, except some parts like digestive system canal etc. Microorganisms are always in 
contact with this shield and are not let go inside. However, any kind of injury may break the 
integrity of the skin-mucosa barrier and can open a gate to the microorganisms to enter body. 
Following their entry, they replicate themselves and retain at a weak part of organism 
(colonization). During the proliferation process the also synthesize and release some toxins to 
damage the host to weaken its defence or to make the environment more proper for their 
survival. Inoculation of microorganism to the implant material can be via direct contact or 
blood stream can act like a high-way to transport the microorganisms from a distant entry 
point to the implant. Either way of exposure can easily initiate colonization of the 
microorganisms on the implant, in other words infection. Implant, itself, has a risk of rejection 
and invasion by the microorganisms would lead and hasten withdrawal of the implant. 
Especially mouth, as a wet and warm atmosphere full of food debris, is an ideal environment 
for bacteria colonization. That makes it a unique part of the body, with the highest type-
multiplicity of microorganism and highest microorganism concentration in one unit of saliva. 
Those factors mentioned above increase the infection risk of dental implants placed in 
edentulous jaw bones to restore chewing, phonation functions and aesthetic. Implant surface 
roughened intentionally to increase bone-implant contact area for more stability and longer 
survival in the bone cavity. Rough surface provide an ideal environment for bacteria 
colonization with its retentive topography and can facilitate increase of bacteria count on 
dental implant. Moreover; incidence of dental implant placement is the higher than all other 
types of implants. This high frequency of application also increases the infection coincidence of 
dental implants. Dental implant infections can be as high as 31,2% [78]. 
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Overcoming implant associated infections is another focus of current researches. Previous 
efforts focused on killing already-colonized microorganisms via several antimicrobial agents 
like antibiotics [79] or debriding the colonies with several techniques like scratching, chemical 
cautery or damaging the colonies via photo thermal effect of laser energy. However current 
concepts have centered on prevention of colonization or may be killing the microorganism as 
they contact the implant. Those studies showing positive effect of antibiotic use on infection 
treatment grounded the idea of keeping antibacterial agents around the implant site during 
healing process. Initial attempts aimed administration of antimicrobials, like tetracycline, 
ciprofloxacin, vancomycin, rifampin/minocyclin, cefoperazone, penicillin/streptomycin, 
gentamicin, around the implant to prevent infection. However; those local administration of 
antibiotics to the implant site topically had limited release time and couldn’t prevent 
development of infection in long term. Idea of gradual release of the antimicrobial substances 
by the implant has leaded coating titanium surface with antibiotics with restricted success 
limited time of degradation process of antimicrobial drug coating [80]. Several local drug 
delivery vehicles like (glycolic, lactic acid, caprolactone, methyl methacrylate polymers, 
chitosan, agarose/hydro-gels, bioactive ceramics, collagen, nanotubes), have been studied to 
prolong releasing period of the antibiotic [81-83]. Choice of delivery medium is dependent on: 
 Type of tissue to be placed (whether soft tissue or bone)  
 Environment  of the implant to be protected (mouth, skin, bone, vessels, heart, genitor-
urinary system, aero digestive system, cranium or any place inside the body) 
 Required releasing time (slow or fast)  
 Biodegradation mechanism  
 How many drugs will be used (single or multiple) and  
 Compatibility with antimicrobial agent to be sustained. 
Simultaneously; antimicrobial prevention concepts have evolved innovative surface 
technologies based on the knowledge that certain metal ions like silver, copper, bismuth and 
zinc have oligodynamic effect (toxic effect on living organisms) on microorganisms [84,85]. 
Target of those researches centered on modifying the titanium dental implant surface with 
these above mentioned metal ions to wall-up a defensive line on the titanium surface and 
protect themselves against bacterial attacks. Similarly zirconium doped titanium presents 
antimicrobial activity beside high epithelial cell attraction and mediate healthy cell 
proliferation to promote formation epithelial cell barrier over the implant surface. 
Development of carbon-nanotube systems grown on implant surface can give the capability 
of controlled release of any drug implanted. It has been shown that they can act as sensing 
probe for various (electrical, thermal, photo or chemical) stimuli. These triggering factors 
can be redox reactions of bone-forming cells (osteoblasts) or connective tissue-forming cells 
(fibroblasts) or any substance specifically released from bacterial wall. As impulses are 
sensed, such materials can release any given drugs to potentially fight bacterial infection, 
reduce inflammation, promote bone growth or reduce fibroblast functions [85, 86].  
3.3.6 Blood coagulation and blood materials interactions 
Any kind of injury may disrupt integrity of blood vessels and cause bleeding. Coagulation 
(hemostasis) mechanism is to stop blood loss, which can also be named as a protective 
mechanism. Injury of the vessel initiates physical, cellular and biochemical chain reaction.  
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Physical change due to trauma (rupture) of vessel walls leads a reflex at surrounding 
muscles of the vessel and they constrict diameter of vessel, so that blood flow thru narrower 
lumen decreases gradually and contribute success of co-working hemostatic mechanisms. 
Besides external trauma, internal biochemical stimulus released by platelets (thromboxane 
A2), has an additive effect on vasoconstriction [75,76]. 
Cellular part of hemostasis mechanism is fulfilled by platelets, formed in the bone marrow 
and release into blood stream as a member of blood cell population. Platelets, though lack of 
reproduction capability and nuclei in their cytoplasm, contain thrombosthenin, that contract 
the platelet cell initially. They can store calcium ions in their cytoplasm and synthesize 
several molecules act actively in inflammation process (pain mediators). 
Main action of platelets in hemostasis mechanism is aggregation via adhesion on another 
and to injured vessel walls. Glycoprotein layer on cell membrane presents a selective 
adhesiveness to the platelet. Under normal conditions this layer rebuff adhesion to healthy 
vessel wall tissue (endothelial cells), while in presence of any injury glycoprotein promotes 
adhesion to the damaged endothelium, collagen bundles supporting vascular wall and one 
another. This increased adherence occurs simultaneously with changing their form as 
swelling and presenting multiple protrusions on their cell membrane and degradation of 
several substances of some attract more platelets and lead increase of those cells in number. 
Increased irregularity of their form and sticky nature of the membrane ease their adhesion 
capability to accumulate at the damaged vessel window. These aggregation and adhesion 
behavior of platelets yield initial clot formation to stop bleeding. 
The third method playing a role in hemostasis mechanism simultaneously with vascular 
response and platelet plug formation is biochemical coagulation cascade. Basically; over 50 
substances found in blood or tissue take place in blood coagulation (procoagulants) or 
anticoagulation (anticoagulants) equilibrium.  Procoagulant factors of those substances (Table 
17) are present in inactive (precursor) form and any stimulus originated traumatized vascular 
endothelium or platelet derivates can activate them to start the coagulation mechanism. These 
extrinsic and intrinsic pathways activate those factors and each activated substance either 
activates another or catalyse their activation process. Final steps of the cascade are change of 
fibrinogen to fibrin via thrombin and formation of fibrin network as an end product. 
 
Factor I fibrinogen 
Factor II prothrombin 
Factor III tissue factor or tissue thromboplastin 
Factor IV calcium ion 
Factor V proaccelerin, labile factor or Ac-globulin 
Factor VII serum prothrombin conversion accelerator, proconvertin or stable factor 
Factor VIII antihemophilic factor, antihemophilic globulin, antihemophilic factor A 
Factor IX plasma thromboplastin component, Christmas factor or antihemophilic factor B 
Factor X Stuart factor or Stuart-Prower factor 
Factor XI plasma thromboplastin antecedent or antihemophilic factor C 
Factor XII Hageman factor 
Factor XIII fibrin-stabilizing factor 
Fletcher factor Prekallikrein 
Fitzgerald factor  High-molecular-weight kininogen 
Platelets thrombocytes  
Table 17. Factors in blood coagulation mechanism 
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Blood clot (thrombus) piece can be detached from a main clot mass or sometimes may occur 
spontaneously without any injury effect. High blood viscosity, high procoagulant serum 
levels or vascular malformations etc. increase intravascular thrombus formation risk. Any 
free thrombus piece can easily be transferred via circulatory system until get stacked in a 
narrower vessel lumen and obliterate an artery (of heart, brain, kidney eye etc.), which may 
cause a severe damage due to occluded blood circulation of the related the tissue. Especially, 
thrombus formation can easily occur on irregular vascular surfaces covered with cholesterol 
plaques or around any vascular implants or grafts like stents used in cardiovascular 
interventions. For a healthy person; anticoagulation mechanism is a protective equilibrium 
that impedes coagulation of whole blood in the vascular system spontaneously, which may 
mean end of life. In other case, as the clotting cascade begins due to any reason, 
anticoagulation mechanism obviates dissemination of the coagulation chain thru whole 
circulation system. Anticoagulant substances found in our body like vascular surface cover, 
glycocalyx, helping platelet or clotting factor repelling, or thrombin binding protein 
thrombomodulin. Fibrin fibers formed during coagulation consumes thrombin and 
eliminates it from the environment. Additionally alpha globulin protein (antithrombin-
heparin cofactor or antithrombin III) also removes thrombin and hinder or delay 
coagulation. In our daily life; anticoagulation is an equilibrium is maintained via vascular 
surface integrity, presence of those anticoagulant substances in the blood or with some 
drugs. 
On the other hand, in case of lack of any of those clotting factors or a deficit in platelet 
structure, function or count lead disturbed coagulation function, which means unstoppable 
bleeding reasoning death. Anticoagulation kept in normal limits is desired to avoid 
intravascular coagulation especially in patients with vascular malformations, vascular grafts 
or stents, atherosclerosis etc. Therefore, those patients are prescribed anticoagulant, like 
heparin, coumarin or 1,3-indandionederivates, to increase coagulation threshold within 
safety limits. 
3.4 Evaluation of materials behavior 
Prior to clinical use of any substance (biomaterial or drug), which is going to be in contact 
with our organism, it should be strictly tested and proven to be non-hazardous for us. Those 
processes to examine this biomaterial can be classified in 3 parts. First requirement is the 
matching physical and chemical properties of the substance, desired to be the same or at 
least compatible with the organism. These materials, therefore, are produced according the 
tissue features, where they are going to be used. According to tissue type; physical strengths 
(tensile, compressive, shear strength, elasticity modulus), thermal properties, 
photoreactivity or translucency, colour, calcification potency, surface structure, chemical 
features, or degradation resistance are modified for ideal adaptation to the environment. 
Those features are examined under laboratory conditions before biologic behavioral tests 
[87]. 
3.4.1 In vitro assessment of tissue compatibility 
Proofed materials in laboratory examinations are ready to be evaluated for their biologic 
performance. According to the tissue(s) which is(are) going to be the environment of the 
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material, related tissue cells are selected to evaluate if the material has a potential to damage 
them, or not. Even materials previously proven to be safe to be use inside the body, should 
be tested if any chemical or major physical modification has been carried out. With this aim 
cell culture systems are the first step evaluation process to assess toxicity of the material for 
related cell types. In vitro term is used to define a test setup that produces cells extracted 
from a living organism outside the body in controlled laboratory conditions. This method is 
helpful to assess the biologic behavior of a material without killing plenty of animals used in 
experiments. Additionally, these in vitro study settings result rapidly, can be performed in 
many different models and can be repeated in a short time. Initially cells are harvested from 
a living organism (animal, human or even plants), kept in proper environmental conditions 
containing all necessary organic and inorganic substances, water, temperature etc., to 
maintain their survival. They should be isolated from other cell groups or microorganisms 
to gain a pure cell population with equivalent features, so that cellular response could be 
same in this population. Genetic structure can be modified to give them immortality to keep 
their production continuously. Gene modification can be used to transform those cells to 
cancer cells to work on such illnesses.  Then cultured cells are passaged and exposed to test 
material or can be stored at -196°C for further studies. Time depended toxicity rate can be 
measured as the count of surviving cells, their physical appearance, functions like 
replication rate or energy production ability (mitochondrial activity) [88].  
Additionally, biologic behavior of a material is not only toxicity but also can be an altering 
effect on cell structure. Especially mutation effect on cell DNA due to test material exposure 
may also change cellular behavior or character and cause cancer. Therefore, such 
mutagenity evaluations can also be made for further investigation. With this purpose 
morphological change can be scanned with scanning electron microscopy or ultrastructural 
transformations can be visualized with transmission electron microscopy. Cellular affinity to 
the substance is eventually another point of interest to measure. Cellular extracts are lined 
on the prepared surface and incubated for a certain period to wait for cell adhesion. Then 
cultured specimens are washed out with water and examined to count attached cell 
numbers.  
Some behavioral and structural alterations can be monitored with various biochemicals, 
spectrophotometric, immunoassay techniques (ELISA-Enzyme-Linked Immunosorbent Assay) 
or dynamic imaging methods like confocal microscopy. These techniques can detect presence of 
a defined substance with various methodology in a sampled moment or in real-time. 
On the other hand, some materials like bone grafts are used as a scaffold for tissue 
engineering procedures that mainly act as a carrier of implanted cells and biomolecules. 
In advanced applications; differentiation of root (stem) cells planted in/on those graft 
materials to bone cells is another desired feature expected from a bone graft material. 
Hence, differentiation effect of test material can also be examined with undifferentiated 
stem cells.   
Besides cell cultures; bacterial or fungi cultures can also be used to evaluate antimicrobial 
effect of the test material. On microorganisms cultured at a medium (on a surface or in a 
solution) are exposed to the test material and surviving microorganisms are counted to 
evaluate their lethal efficacy [89,90]. 
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3.4.2 In vivo assessment of tissue compatibility and animal models 
Third step of biologic behavioral tests are in vivo (animal) experiments. Only approved 
substances with in vitro examinations are subjected to in vivo experiments, so that excessive 
scarification of experiment subjects is minimized. Depending on the purpose of biomaterial; 
the substance is tested whether it cause any allergic reaction (sensitization), tissue 
inflammation and rejection reaction (irritation). It is also implanted under the skin 
(intracutaneously) or in a prepared bone cavity (intrabony) to evaluate local tissue response. 
Additionally following administration in to the body (no matter what way of administration 
was chosen) acute or subacute damages to all organ systems (systemic toxicity) are 
evaluated after implantation via examining each organ with microscopic imaging or 
biochemical analyses. Genotoxicity potential of the studied material is investigated with 
changes of genetic structure of the cells exposed to the material. Changes of the healthy 
tissue can be assessed with comparison of those tissue samples exposed to the substance 
with healthy tissue structures of the same spice with different methodology. Tissue 
morphology can be evaluated with microscopic techniques like light microscopy, scanning 
electron microscopy, transmission electron microscopy, confocal microscopy etc. or some 
physical tests (tensile strength, shear strength or compression tests) can be used to evaluate 
physical strength of hard tissues like bone and tooth, or even (sometimes) soft tissues. 
Biochemical alterations, before and after application of the researched material, can also be 
compared to evaluate tissue response or its reaction path to the material. Additionally 
calcified tissues like bone or tooth can be followed up via X-ray images (radiographically). 
Study designs can be based on time dependent comparative research methodology and can 
use assessment of half-life of radioactively singed atoms implanted to the study substance to 
be placed in to the body [91].  
Samples to be examined should be free of any contamination (pure), packed properly and 
sterilized according their structure (with gamma-radiation, steam+heat, ethylene oxide or 
plasma). Local reaction to the material can be measured with comparison of healthy tissue, 
physiologic tissue healing or healing process of a standard material well-known and 
documented previously. In such methodology, unless systemic efficacy is not in 
consideration, more than one substance can be tested in one organism to make a healthy 
comparison. However, at least 6 subjects should be studied for each group for statistical 
analysis. If time depended results are required one group of animals should be prepared for 
each time interval. Examinations regarding systemic effect of the substance necessitate use 
of one material on one animal each time, which eventually increase number of animals. 
Regarding systemic toxicity, irritation or hypersensitivity repetitive dose applications can be 
used, which also means raised animal number. Following application of test material, the 
subjects are kept in a convenient habitation conditions. Responses are monitored after 
scarification or real-time with suitable probing in tissues and body fluids histologically, 
radiologically, chemically, thermally or immunohistochemically etc. For evaluation of 
results; obtained raw data is analysed statistically with parametric and nonparametric tests.  
Physical or chemical tests can be performed to evaluate structural, chemical or physical 
strength changes of the material itself after using in the organism. Especially force bearing 
materials like bone plates or metallic prosthesis or dental implants can be examined 
regarding corrosion potential, micro/macro cracks or plastic deformation, so that survival of 
material can be estimated under compressive, tensile and shear strengths besides corrosive 
effect of body fluids [92]. 
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3.5 Dental implants  
Other than restorative dentistry the rehabilitation of teeth losses is a major concern for 
clinicians. Replacing the teeth with human-made one has been one of the greatest challenges 
in field of dental medicine. Mechanical features like macro anatomy, micro surface 
topography of dental implants necessitate a special concern to give a life-long service in an 
environment where repeating bite or chewing forces are loaded from different directions. 
These physical design properties are expected to neutralize those loaded chewing forces or 
at least should minimize compressive stresses on the bony bed where they were implanted.  
Moreover; regarding resistance against metal fatigue choice of material is highly important 
in case of cycling compressive, shear and tensile loads. Dental implants are partly placed 
into the jaw bones where in contact with blood and also have a part left in the oral cavity 
where exposed to saliva. Those body fluids that have lipophilic and hydrophilic affinity and 
enzymatic activity potentially dissolve and corrode materials. Hence corrosion resistance of 
the dental implant material should be high enough both to sustain their physical strength in 
acceptable limits and also to minimize local or systemic toxicity risk due to corrosion 
particles. However; first place for significance ranking of dental implant material, likewise 
in all biomaterials, is its compatibility with the surrounding tissues (biocompatibility). 
Therefore; several materials and alloys have been tried for decades to find out the ideal 
biocompatibility with excellent physical features. Titanium and zirconium elements have 
been well documented and presented to have better tissue biocompatibilities and acceptable 
physical properties, when compared to others [93,94]. It is been shown that alloys of these 
materials can present augmented biologic and physical features while corrosion aspect of 
those alloys is still questionable.  With this regard Ti-6Al-4V, Ti-6Al-7Nb, Ti-5Al-2Nb-1Ta, 
Ti-30Ta and Ti-Zr alloys have been studied in several studies to enhance mechanical and 
biologic properties of titanium or zirconium [95-99]. Those alloys have been used as base 
material or as coating for augmented features. More recent studies focusing on Ti-Zr alloy 
have promising results which show evidences of elimination of disadvantages of both 
substances while improving biocompatibility. 
Except using alloys to improve biocompatibility several techniques have been used to 
modify implant surface that is in contact with bone. Changing micro-structural, chemical or 
ionic structure of dental implant material to make it more attractive for surrounding bone 
cells (osteoblast) and allow it to bind calcium and phosphate ions of neighboring bony bed 
[100].  
Following preparation of a place in the jaw bone dental implant is placed into the cavity and 
left for healing. During the healing process blood clot cover implant surface which is not in 
close contact with bone. Those two different neighboring structures (bone and blood clot) 
initiate healing process which means integration of implant to surrounding bone tightly.  
Parts of implant surface at direct bony contact may develop chemical connection with 
calcium and phosphate of bony hydroxyapatite crystal. Developing a bone contact on the 
implant surface exposed to blood clot needs more time to have bony connection. Overlaying 
clot undergoes transformation turn into bone tissue, so that implant connects to 
surrounding bone (osteointegration). Both titanium and zirconium materials and their alloys 
are capable to show osteointegration. Considering this process, implant surface must be 
available for osteoblast habitation, in other terms implant surface should have an optimum 
surface roughness values to let the bone cells attach on tightly. Surface treatment also helps 
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to increase surface magnitude with roughening, which also contribute extension of bone-to-
implant contact area. Following adhesion; cells synthesize osteoid bone matrix (immature 
bone) that acts like a template leading calcium hydroxyl apatite crystal precipitation in 
(calcification). Therefore, osteoblastic attachment is inevitable for osteointegration, which 
also means “success” [101]. Therefore; increasing surface roughness has been worked out 
with different techniques, like sand blasting, acid etching, abrading with SiC paper, 
microarc oxidation, spark erosion, lasering or their combinations [102,103]. Sand blasting is 
a well-documented method to improve surface porosity, as well as altering several physical 
properties of the metal (fracture, fatigue, tensile strength etc.) [104].  
Various parameters have been modified for optimization both for roughness and bone cell 
(osteoblast) adhesion to the surface. Different materials like aluminium oxide, TiO2, 
hydroxyapatite, calcium phosphate and zirconium oxide have been studied in different 
particle sizes in combination or separately [105]. Parameters like blasting speed, particle 
diameter, and particle ratio in the blowing air, blasting atmosphere and temperature can 
affect surface topography. Type of blasting material is also important with the respect that 
during the blasting process some particles can be stacked into the titanium surface due to 
high velocity and may remain on even after cleaning processes following blasting. It should 
be considered that those blasting particles remaining on the implant surface can alter tissue 
reaction to the implant material in positive or negative direction. With this regard, choice of 
blasting materials among biocompatible ones would accelerate osteointegration process, 
while substances with low or no biocompatibility can be expected to influence this process 
negatively [106]. It should also be considered that these blasting materials remaining on the 
implant surface may undergo corrosion and may result rejection of the implant or toxicity 
by the time as well [107]. Therefore, analysis of the titanium surface following blasting can 
be advised to evaluate any remnants of blasting materials if such susceptible material had 
been used for blasting. Owing that; several chemicals or their combinations have been tried 
out and some are currently used to modify implant surface to enhance roughness. 
Phosphoric acid and its derivates, HF, HNO3, HCl and H2SO4 the most frequently used 
chemical etching agents to modify titanium surface solely or in combination. It is also noted 
that temperature is an important factor that increase the corrosive effect of chemicals [108]. 
Even though several research groups showed that acid treatment is more useful then alkali 
solutions to improve surface roughness of titanium [109], there are studies showing that 
alkali solutions are efficient for surface treatment of titanium implants in nanoscale and 
moreover can be advantageous to give hydrophilic structure on the implant surface, which 
provide augmented tissue affinity to the titanium surface [110]. It is also been stated that 
alkali- and heat-treated titanium surface can accelerate and improve bone-implant contact 
area due to increased surface roughness [111]. As understood from those results; alkali 
treatment can be attributed as less aggressive than acid etching method, but can be used 
following acid treatment and forms nanoroughness on the titanium surface that can attract 
bone cells to attach on. Hydrogen peroxide, likewise alkali treatment, and heat treatment 
can improve cell adhesion and create hydrophilic nature for titanium [112]. Moreover; alkali 
(NaOH) treated titanium surfaces can induce biomimetic apatite debris formation on the 
implant surface, which can be attributed as chemical binding of titanium and bony apatite. 
This bone-like apatite focuses act as bone calcification nuclei and initiate bone formation.  
Surface treatment with previously mentioned methods, sand blasting and acid or alkali 
etching, do contaminate the titanium surface, of which remnants cannot be avoided, 
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eradicated or neutralized totally all the time. However, laser energy can modify the titanium 
or titanium alloy surfaces without contamination [113]. Laser energy can change the 
titanium or its alloys with heat (photothermal) effect or intense pulsed wave form of laser 
energy (photomechanic) effect like embossing. For this purpose, certain wavelengths, like 
neodymium: yttrium aluminium garnet (Nd-YAG) laser-355 nm and carbon dioxide laser-
10600 nm, have been well documented [114] and taken an inevitable place in industrial 
surface treatment industry. Pulsed Nd-YAG laser with 10 Hz repetition rate has been 
demonstrated to give the opportunity to control micro-topography as desired [115]. 
However, those wavelengths work with photothermal effect and modify the titanium 
surface via melting. Even laser surface treatment is defined to give the control for desired 
surface topography melting method does not create a perfect surface structure. Therefore, 
shorter (femto or pico second) pulses can generate more controlled surface shape due to 
lower heat formation [116]. Femtosecond laser pulses can engrave surface topography at 
micro or nano scales, which give the 100% control facility of surface texturing. Control of 
roughness depth and geometry on the implant surface also gives the possibility for selective 
cell attraction to the implant surface. Such laser-treated surfaces can distract inflammatory 
cells, responsible from tissue response to implant surface, and contribute to suppression of 
early inflammatory events, which may lead rejection [117]. Similarly, laser-texturing can 
make it possible to attract certain cells of which long-term function is a prerequisite for their 
adhesion, like epithelial cells and osteoblasts. Those cells attach directly to the implant 
surface, if convenient roughness values can be yielded with treatment. Connective tissue 
cells (fibroblast) tend to attach less roughened surfaces, when compared with bone cells 
(osteoblasts) [118]. Wavelengths proven to be innocuous to the titanium surface like erbium: 
yttrium aluminium garnet (Er:YAG) laser-2940 nm, recently, have been documented as a 
laser type that may modify the titanium surface at certain power settings as low as 200 
mJ/10Hz [119]. On the other hand, degree of surface roughness can alter surface adhesion 
potential of several microorganisms as well as body cells [120]. Owing that affinity potential, 
implant surfaces can be modified gradually according to the location where cell adhesion is 
targeted, while microbial attacks are repulsed. 
Titanium surfaces treated with micro-arc (plasma electrolytic) oxidation (MAO) can also 
improve surface porosity and its alloys, contributing cellular activity for osteointegration 
[121]. Correspondingly; MAO procedure facilitates cell adhesion capability of titanium 
surface with enhanced hydrophilicity [122].  
4. Summary 
In conclusion, physical, chemical and biologic features of biomaterials are chosen and 
determined considering their function and required durability in situ besides biocompatibility. 
Accelerative development in material science, especially in nano and optoelectric sciences 
makes exploration of new materials or enhancement of conservative biomaterials. 
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